EP Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233K | Sell |
713
-285
| -29% | -$92.9K | ﹤0.01% | 1164 |
|
|
2025
Q1 | $269K | Buy |
+998
| New | +$269K | ﹤0.01% | 965 |
|
|
2024
Q4 | – | Sell |
-732
| Closed | -$201K | – | 1239 |
|
|
2024
Q3 | $201K | Buy |
+732
| New | +$201K | ﹤0.01% | 1045 |
|
|
2023
Q4 | – | Sell |
-1,177
| Closed | -$208K | – | 816 |
|
|
2023
Q3 | $208K | Buy |
1,177
+71
| +6% | +$12.6K | ﹤0.01% | 658 |
|
|
2023
Q2 | $225K | Hold |
1,106
| – | – | ﹤0.01% | 627 |
|
|
2023
Q1 | $222K | Sell |
1,106
-10
| -0.9% | -$2K | ﹤0.01% | 556 |
|
|
2022
Q4 | $265K | Buy |
+1,116
| New | +$265K | ﹤0.01% | 492 |
|